杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/06/17 | 1,760 | 1,763 | 1,740 | 1,745 | -6 | -0.3% | 104,300 |
2021/06/16 | 1,744 | 1,754 | 1,734 | 1,751 | +8 | +0.5% | 95,800 |
2021/06/15 | 1,746 | 1,748 | 1,728 | 1,743 | -13 | -0.7% | 171,800 |
2021/06/14 | 1,750 | 1,756 | 1,743 | 1,756 | +16 | +0.9% | 88,900 |
2021/06/11 | 1,750 | 1,753 | 1,731 | 1,740 | -5 | -0.3% | 168,000 |
2021/06/10 | 1,750 | 1,756 | 1,734 | 1,745 | +5 | +0.3% | 131,000 |
2021/06/09 | 1,733 | 1,748 | 1,727 | 1,740 | +10 | +0.6% | 110,000 |
2021/06/08 | 1,715 | 1,737 | 1,710 | 1,730 | +37 | +2.2% | 169,600 |
2021/06/07 | 1,685 | 1,703 | 1,682 | 1,693 | -10 | -0.6% | 183,400 |
2021/06/04 | 1,707 | 1,709 | 1,695 | 1,703 | +3 | +0.2% | 146,500 |
2021/06/03 | 1,665 | 1,702 | 1,663 | 1,700 | +27 | +1.6% | 260,900 |
2021/06/02 | 1,683 | 1,689 | 1,672 | 1,673 | -21 | -1.2% | 185,100 |
2021/06/01 | 1,710 | 1,712 | 1,685 | 1,694 | -15 | -0.9% | 143,000 |
2021/05/31 | 1,713 | 1,737 | 1,705 | 1,709 | -18 | -1% | 116,800 |
2021/05/28 | 1,705 | 1,728 | 1,701 | 1,727 | +37 | +2.2% | 128,400 |
2021/05/27 | 1,700 | 1,709 | 1,690 | 1,690 | -12 | -0.7% | 186,200 |
2021/05/26 | 1,733 | 1,734 | 1,702 | 1,702 | -32 | -1.8% | 131,900 |
2021/05/25 | 1,737 | 1,737 | 1,725 | 1,734 | -4 | -0.2% | 163,200 |
2021/05/24 | 1,730 | 1,746 | 1,725 | 1,738 | -3 | -0.2% | 121,000 |
2021/05/21 | 1,740 | 1,753 | 1,739 | 1,741 | -1 | -0.1% | 126,400 |
2021/05/20 | 1,753 | 1,765 | 1,742 | 1,742 | -16 | -0.9% | 91,900 |
2021/05/19 | 1,734 | 1,758 | 1,734 | 1,758 | +13 | +0.7% | 144,900 |
2021/05/18 | 1,729 | 1,745 | 1,721 | 1,745 | +16 | +0.9% | 147,000 |
2021/05/17 | 1,726 | 1,749 | 1,722 | 1,729 | -1 | -0.1% | 188,800 |
2021/05/14 | 1,700 | 1,739 | 1,691 | 1,730 | +40 | +2.4% | 222,400 |
2021/05/13 | 1,705 | 1,713 | 1,689 | 1,690 | -8 | -0.5% | 227,100 |
2021/05/12 | 1,830 | 1,834 | 1,693 | 1,698 | -184 | -9.8% | 657,700 |
2021/05/11 | 1,908 | 1,912 | 1,882 | 1,882 | -26 | -1.4% | 176,400 |
2021/05/10 | 1,916 | 1,921 | 1,905 | 1,908 | -28 | -1.4% | 159,000 |
2021/05/07 | 1,942 | 1,952 | 1,932 | 1,936 | +7 | +0.4% | 75,800 |
2021/05/06 | 1,915 | 1,970 | 1,915 | 1,929 | +16 | +0.8% | 258,700 |
2021/04/30 | 1,912 | 1,937 | 1,906 | 1,913 | -3 | -0.2% | 161,600 |
2021/04/28 | 1,900 | 1,925 | 1,897 | 1,916 | +7 | +0.4% | 130,600 |
2021/04/27 | 1,904 | 1,920 | 1,899 | 1,909 | +2 | +0.1% | 141,100 |
2021/04/26 | 1,899 | 1,908 | 1,898 | 1,907 | -13 | -0.7% | 146,500 |
2021/04/23 | 1,920 | 1,926 | 1,914 | 1,920 | -6 | -0.3% | 132,100 |
2021/04/22 | 1,911 | 1,926 | 1,910 | 1,926 | +26 | +1.4% | 173,400 |
2021/04/21 | 1,890 | 1,903 | 1,881 | 1,900 | +5 | +0.3% | 183,100 |
2021/04/20 | 1,898 | 1,906 | 1,891 | 1,895 | -16 | -0.8% | 96,500 |
2021/04/19 | 1,919 | 1,921 | 1,911 | 1,911 | -3 | -0.2% | 63,400 |
2021/04/16 | 1,911 | 1,916 | 1,900 | 1,914 | +7 | +0.4% | 73,300 |
2021/04/15 | 1,906 | 1,914 | 1,902 | 1,907 | +4 | +0.2% | 75,700 |
2021/04/14 | 1,908 | 1,912 | 1,892 | 1,903 | -7 | -0.4% | 135,200 |
2021/04/13 | 1,918 | 1,923 | 1,910 | 1,910 | +2 | +0.1% | 93,800 |
2021/04/12 | 1,900 | 1,912 | 1,897 | 1,908 | +13 | +0.7% | 118,000 |
2021/04/09 | 1,905 | 1,913 | 1,895 | 1,895 | +1 | +0.1% | 119,900 |
2021/04/08 | 1,903 | 1,907 | 1,892 | 1,894 | -22 | -1.1% | 201,200 |
2021/04/07 | 1,911 | 1,923 | 1,906 | 1,916 | -4 | -0.2% | 137,800 |
2021/04/06 | 1,935 | 1,940 | 1,916 | 1,920 | -15 | -0.8% | 140,200 |
2021/04/05 | 1,939 | 1,942 | 1,927 | 1,935 | +10 | +0.5% | 65,100 |
951~
1000
件表示中 / 3694件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 146,400円 | +8.8% | +99.9% | 3.55% | 9.35倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ジーエヌアイ | 231,600円 | +21.7% | +999.9% | 0.00% | 9.64倍 | 3.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 305,000円 | +3.0% | +27.5% | 2.62% | 19.31倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 220,600円 | +0.4% | -8.4% | 2.40% | 28.32倍 | 1.60倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 87,800円 | +20.3% | - | 0.00% | 154.85倍 | 1.15倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム